Skip to main content
. 2024 Apr 6;11:100230. doi: 10.1016/j.dadr.2024.100230

Table 2.

Treatment effect h of NTX-BUP vs. Placebo within and between race/ethnicity status.

PHQ-9
TEA Total score
MA Craving
Racial and ethnic Subgroups h(95% CI) P-value‡ P-value† h(95% CI) P-value‡ P-value† h(95% CI) P-value‡ P-value†
Non-Hispanic White -0.8 (1.9, 0.4) 0.77 Ref 3.1 (0.9, 5.3) 0.01 Ref -9.3 (-14.7, −3.7) <0.01 Ref
Non-Hispanic Black -0.7 (-3.8, 2.4) 0.99 0.99 0.4 (-4.1, 4.9) 0.99 0.84 -13.5 (-26.5, −0.6) 0.16 0.99
Hispanic -2.8 (-5.5, −0.1) 0.18 0.56 7.8 (2.5, 13.1) 0.01 0.32 -7.7 (-17.9, 2.4) 0.54 0.99
Non-Hispanic Other -2.9 (-5.8, 0.0) 0.22 0.53 7.9 (2.8, 13.1) 0.00 0.25 -13.0 (-28.1, 2.1) 0.36 0.99

Note: ‡P-values are for mean change from baseline in treatment effect h within racial and ethnic subgroups and were adjusted for 4 multiple comparisons using the Bonferroni correction; P-values are for comparisons in treatment effect h between racial and ethnic subgroups and were adjusted for 3 multiple comparisons using the Bonferroni correction